Martin Auster - Jan 2, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Financial Officer
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 06:26 PM
Previous filing
Dec 19, 2023
Next filing
Mar 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (right to buy) Award $0 +125K $0.00 125K Jan 2, 2024 Common Stock 125K $2.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total shares subject to the Option shall vest on the one-year anniversary of January 2, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through such date.